Mechanisms of control of cytomegalovirus infection
Main researcher
: JONJIĆ, STIPAN (95983) Assistants
DORIĆ, MILJENKO (85032)
LUČIN, PERO (142314)
CRNKOVIĆ, IRENA (900105)
ZORICA, IRENA (900700)
KUČIĆ, NATALIJA (900752)
KRMPOTIĆ, ASTRID (900856)
Type of research: basic Duration from: 02/01/91. to 02/01/94. Papers on project (total): 36
Papers on project quoted in Current Contents: 12
Institution name: Medicinski fakultet, Rijeka (62) Department/Institute: Department of physiology and immunology Address: Braće Branchetta 20 City: 51000 - Rijeka, Croatia
Communication
Phone: 385 (0)51 51-32-22
Fax: 385 (0)51 51-49-15
Summary: The experiments planed in this project are aimed to
investigate the role of various components of innate and acquired
immunity involved in control of acute CMV infection as well as in
establishment and maintenance of CMV latency. T lymphocytes involved in
CMV control belong to both, CD8+ and CD4+ T cell subset. We have
previously shown that CD8+ T cells do not require the cooperation of CD4
helper T cells to function (Jonjić et al. J. Exp. Med. 169:1199 - 1212,
1989). Mice depleted of CD4 subset were capable of controlling and
eliminating infectious virus from all tissues with the exception of the
salivary gland, where the CD4+ T cells are essential to terminate
productive infection. The most compelling evidence for the dominant
protective activity of CD8+ T cells is provided by cell transfer studies
where murine CMV (MCMV) infected immunodeficient mice were transferred
with syngeneic lymphocytes from mice that had recovered from CMV
infection. However, despite their prominent role CD8+ T cells are
neither indispensable for CMV control nor they can terminate the
productive infection (Jonjić et al., J. Virol. 64:5457-5464. 1990.).
Namely, CD8-subset-depleted mice clear the virus by CD4-subset-dependent
mechanism with clearance kinetics indistinguishable from that of normal
animals. Among several possibilities how CD4 cells compensate the lack of
CD8 cells the obvious one is that they facilitate the production of
neutralizing antibodies. However, this possibility is recently excluded
by the experiments with mice carrying deletion of the transmembrane
exon of IgM heavy chain and therefore lack B cells and antibodies
(Jonjić et al. J.Exp. Med. 179:1713, 1994.). B cell deficient mice
depleted of CD8 subset also clear the virus, even in salivary glands,
definitely confirming that the lack of antibodies could not be the
explanation for CMV persistence in CD4 depleted mice. Yet, although
essential for the compensatory antiviral activity in CD8 depleted host,
CD4 T lymphocytes are not protective on their own. This findings
strongly point to the role of cytokines in control of CMV infection. The
experiments using in vivo neutralization of IFN-gamma and TNF-alpha
(Lučin et al., J. Virol. 66:1977-1984, 1992., Pavić et al. J. Gen.
Virol. 74:2215-2223, 1993.) provided evidence for the role of this
cytokine in T-cell mediated virus clearance. In vivo depletion of
IFN-gamma abolished the antiviral activity of CD4 T cells in
immunocompetent as well as in CD8 subset-depleted mice. The results also
imply a role of IFN-gamma in the CD8-subset mediated control of CMV
infection. The function of IFN-gamma, in concert with TNF-alpha, is to
directly regulate the replication of CMV in cytokine conditioned cells.
In addition to direct antiviral activity the role of cytokines may be
to counteract the evasion potential of CMV. It is well established
that early viral gene products of MCMV block the presentation of
immediate early antigens to CTL. Also the reduction of cell-surface MHC
class I was observed by MCMV early gene products. However, despite the
lack of presentation in vitro and down-regulation of cell surface class
I molecules, CD8+ T cells specific for CMV antigens are generated and
have protective role in vivo. It appears that cytokines released by
cells from infected tissue and by the cells of the immune system
counteract the evasion potential of CMV (Hengel et al., J. Virol.
68:289-297, 1993. Also, the preincubation of cells with IFN-gamma
prevents the MCMV induced effect on MHC class I expression and rescue
the antigen presentation. To asses the compensatory capacity of CD4+
lymphocytes we also used b2-microglobulin-deficient mice, which fail to
express MHC class I molecules and lack peripheral CD8+ T lymphocytes. We
show that virus organ titers and virus clearance kinetics are not altered
in b2-microglobulin mutant mice. There was no indication for the
diminished virus propagation. These mice suffered form the lack of CD8+ T
lymphocytes that was only partially compensated by CD4+ T lymphocyte
function. An organ specific function of NK cells was observed and was
not affected by the mutation. The unique immune control of salivary
gland infection was maintained in MHC class I deficient mice.
Altogether the data confirm the role of MHC class I molecules in immune
surveillance but question their biological impact regarding virus cell
interaction and virus productivity (Polić et al., J. Gen. Virol., in
press).
Keywords: T lymphocytes, cytomegalovirus, cytokines, antiviral antibodies, IFN-gamma, TNA-alpha
Research goals: In an immunocompetent host CMV usually does not
cause any clinical symptoms, but rather evades into a state of latency that
can reactivate into a productive infection whenever the immune control is
compromised. The experiments were aimed to study the immune mechanisms
involved in control of cytomegalovirus infection. The infection of mice
with murine CMV has been used as a suitable animal model for human CMV
infection. The relative importance of the different immune effector
mechanisms that are generated during the primary infection was tested. The
immune mechanisms operative in the salivary gland, a privileged site for
CMV replication and a place of productive virus replication even in
immunocompetent host, was of particular importance. Here we have
characterized the protective mechanisms by CD4 subset with special emphasis
on the role of cytokines, IFN-gamma and TNF-alpha. Following mechanisms
were proposed to explain how CD4 cells compensate the lack of CD8 cells:
1. Enhancement the specific antibody response, 2. Release of cytokines
that have direct and indirect antiviral activity, 3. Direct effect on
viral replication by generating MHC class II-restricted lysis of infected
cells, and 4. Enhancement of antiviral activity of NK cells. Using the
model of B cell deficient mice we asked the question whether antiviral
antibodies are essential for resolution of acute infection as well as for
the establishment and maintenance of latency.
COOPERATION - PROJECTS
Name of project
: SFB 322/B6 Praesentation viraler
Proteinantigene durch MHC-Molekuele: Prozessierung und
Peptid-Rezeptor-Interaktion (principal investigator Prof. Dr. U.
Koszinowski) Name of institution: Institut fuer Mikrobiologie, Abteilung
Virologie, Universitaet Ulm City: 89069 - Ulm, Deutschland
Name of project
: DFG Ko 571/8-5 Regulation der Virusvermehrung
bei latenter und rekurrierender muriner Cytomegalovirus-Infektion
(principal investigator Prof. Dr. U. Koszinowski) Name of institution: Institut fuer Mikrobiologie, Abteilung
Virologie, Universitaet Ulm City: 89069 - Ulm, Deutschland
Name of project
: DFG Ko 571/11-2 Cytomegalovirus-Tropismus fuer
die Speicheldruese und immunilogische Kontrolle (principal investigator
Prof. Dr. U. Koszinowski) Name of institution: Institut fuer Mikrobiologie und Immunologie,
Abteilung virologie, Universitaet Ulm City: 89069 - Ulm, Deutschland
Name of project
: SFB, projekt C8 Selective Modulations des
Vesikularen Transporters durch Cytomegalovirus (principal investigator
Prof. Dr. U. Koszinowski) Name of institution: Abteilung Virologie, Universtaet Heidelberg City: 69120 - Heidelberg, Deutschland
COOPERATION - INSTITUTIONS
Name of institution
: Institut fuer Mikrobiologie und
Immunologie, Abteilung Virologie, Universitaet Ulm Type of institution: University/Faculty Type of cooperation: Joint project City: 89069 - Ulm, Deutschland
Name of institution
: Zentrum fuer Hygiene, Institut fuer
Medizinische Virologie, Universitaet Heidelberg Type of institution: University/Faculty Type of cooperation: Joint project City: 69120 - Heidelberg, Deutschland Other information about the project.